Mike Lin ESA-SRB-NZSE-CaSR 2026 in conjunction with ENSA

Abstracts this author is presenting:

• Long-Term Persistence with Denosumab and Bisphosphonates after Fracture and Its Association with Clinical Outcomes: A Population-Based Linked Cohort Study — ESA and NZSE Clinical Orals and Lightning Talks
• Denosumab withdrawal - preventing the rebound  — ENSA Session